AAPG Competitors & Alternatives
Compare Ascentage Pharma Group International with similar stocks in the same industry
Biotechnology
AAPG
Main Stock$16.71
Tradestie Score
41
Market Cap
$3.68B
Revenue Growth
0.3%
Analyst Upside
+183.9%
Top Competitors
238 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MNKD
Mannkind Corporation
|
$4.07
|
$1.65B | - | 49 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$44.72
|
$1.63B | - | 45 | Compare |
|
BHVN
Biohaven Ltd.
|
$13.68
|
$1.57B | - | 42 | Compare |
|
VCEL
Vericel Corporation
|
$42.30
|
$1.56B | 88.9 | 63 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$110.07
|
$1.55B | - | 45 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$38.50
|
$1.55B | 12.3 | 52 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$37.31
|
$1.55B | - | 45 | Compare |
|
NVAX
Novavax Inc
|
$8.86
|
$1.54B | - | 36 | Compare |
|
AUPH
Aurinia Pharmaceuticals Inc
|
$16.57
|
$1.50B | 7.3 | 41 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$49.01
|
$1.50B | - | 38 | Compare |
More AAPG Analysis
Data updated: Aug 25, 2026 | Industry: Biotechnology (SIC 2834)
238 stocks in this industry